id
processing priority
4
site type
0 (generic, awaiting analysis)
review version
11
html import
20 (imported)
first seen date
2024-03-26 01:50:26
expired found date
-
created at
2024-06-20 06:16:51
updated at
2026-02-28 14:18:18
length
16
crc
5740
tld
2211
nm parts
0
nm random digits
0
nm rare letters
0
is subdomain of id
-
previous id
0
replaced with id
0
related id
-
dns primary id
dns alternative id
0
lifecycle status
0 (unclassified, or currently active)
deleted subdomains
0
page imported products
0
page imported random
0
page imported parking
0
count skipped due to recent timeouts on the same server IP
0
count content received but rejected due to 11-799
0
count dns errors
0
count cert errors
0
count timeouts
0
count http 429
0
count http 404
0
count http 403
0
count http 5xx
0
next operation date
-
server bits
—
server ip
-
mp import status
20
mp rejected date
-
mp saved date
-
mp size orig
16694
mp size raw text
1066
mp inner links count
1
mp inner links status
20 (imported)
title
Foresight Diagnostics
description
Foresight Diagnostics make the world’s most sensitive ctDNA/cfDNA liquid biopsy minimal residual disease (MRD) test that detects the earliest hints of cancer relapse.
site name
author
updated
2025-12-30 01:31:11
raw text
Home | Foresight Diagnostics Technology Partnership About News & Publications Contact We're Hiring! See clearly . Act decisively . A highly sensitive liquid biopsy minimal residual disease (MRD) test that detects the earliest hints of cancer relapse. Now accepting inquiries from academic and research institutions to access PhasED-Seq ctDNA-MRD assay in Investigator Initiated Studies Apply here Detect relapse 200+ days earlier By detecting 1 part per million See what others miss Latest Updates Jan 25, 2024 PhaseEd-Seq MRD Detection May Provide Effective Alternative to Standard Imaging in LBCL Jan 25, 2024 Improving MRD assessment and response criteria in DLBCL: insights into PhasED-Seq Video Journal of Hematology & HemOnc Jan 08, 2024 Allogene makes ‘bold’ pivot, stopping pivotal trials in pursuit of first-line CAR-T cures Certifications: CLIA: 06D2287941 > ISO 27001 Cert No. C...
redirect type
0 (-)
block type
0 (no issues)
detected language
1 (English)
category id
Medicine [en] (226)
index version
2025123101
spam phrases
0
text nonlatin
0
text cyrillic
0
text characters
777
text words
132
text unique words
114
text lines
38
text sentences
6
text paragraphs
0
text words per sentence
22
text matched phrases
2
text matched dictionaries
3
links self subdomains
0
links other subdomains
links other domains
links spam adult
0
links spam random
0
links spam expired
0
links ext activities
0
links ext ecommerce
0
links ext finance
0
links ext crypto
0
links ext booking
0
links ext news
0
links ext leaks
0
links ext ugc
links ext klim
0
links ext generic
0
dol status
0
dol updated
2025-12-30 01:31:11
rss path
rss status
1 (priority 1 already searched, no matches found)
rss found date
-
rss size orig
0
rss items
0
rss spam phrases
0
rss detected language
0 (awaiting analysis)
inbefore feed id
-
inbefore status
0 (new)
sitemap path
sitemap status
34 (reserved: import paused pending content quality/relevance assessment after importing first 500 pages)
sitemap review version
2
sitemap urls count
111
sitemap urls adult
0
sitemap filtered products
0
sitemap filtered videos
0
sitemap found date
2024-03-23 11:58:56
sitemap process date
2024-09-28 13:43:26
sitemap first import date
-
sitemap last import date
2026-02-28 14:18:18